Publication | Open Access

Therapeutic potential of chimeric anti-(ganglioside GD3) antibody KM871: antitumor activity in xenograft model of melanoma and effector function analysis

Antibody Km871Cancer ImmunosurveillanceMedicineMelanomaImmunologyImmune Checkpoint InhibitorAnti-cancer AgentImmunotherapyPharmacologyTumor MicroenvironmentTumor BiologyGanglioside Gd3Xenograft Model